The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Novartis; Roche
Travel, Accommodations, Expenses - Amgen; Roche
 
Research Funding - Celltrion; Lilly; Samsung Bioepis
Travel, Accommodations, Expenses - Astellas Pharma; Roche
Additional one-year follow-up study to evaluate safety and survival in patients who have completed neoadjuvant-adjuvant treatment with SB3 (trastuzumab biosimilar) or reference trastuzumab in HER2-positive early or locally advanced breast cancer.
 
Xavier Pivot
No Relationships to Disclose
 
Igor Bondarenko
No Relationships to Disclose
 
Zbigniew Nowecki
No Relationships to Disclose
 
Mikhail Dvorkin
No Relationships to Disclose
 
Ekaterina Trishkina
No Relationships to Disclose
 
Tomasz Sarosiek
No Relationships to Disclose
 
Marek Wojtukiewicz
No Relationships to Disclose
 
Yaroslav V. Shparyk
No Relationships to Disclose
 
Vladimir Moiseyenko
No Relationships to Disclose
 
Younsoo Kim
Employment - Samsung Bioepis
 
Jae Yun Lim
Employment - Samsung Bioepis
Stock and Other Ownership Interests - Samsung Biologics